News & Press

Densitas Announces the Commercial Release of intelliMaven™: The First GPT AI Companion to Elevate Mammography Quality Standards.

April 16, 2024

The market leader in Operational AI solutions will showcase its new GPT AI solution at the upcoming SBI symposium in Montreal. HALIFAX, NS, April 3rd, 2024 – Densitas®, a global leader in artificial intelligence solutions for breast cancer screening, announces the commercial release of intelliMaven™, a groundbreaking GPT AI assistant for mammography quality. Together with Densitas’ flagship product intelliMammo®, intelliMaven™ […]

iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation

April 16, 2024

Provides a holistic breast health solution, including breast cancer screening focused on quality, safety and efficiency, breast cancer detection, breast density assessment, and risk evaluation Expands access to iCAD’s AI-powered ProFound Breast Health Suite and Densitas’ AI solutions to patients and medical professionals worldwide NASHUA, N.H. and HALIFAX, Nova Scotia, April 09, 2024 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a […]

Densitas® Selects CancerIQ to Power Lifetime Risk, Patient Adherence as Part of its Industry Leading Mammography Quality AI Platform

December 11, 2023

CHICAGO, Nov. 26, 2023 /PRNewswire/ – Densitas Inc., a global leader in artificial intelligence solutions for breast cancer screening, today announced a partnership with CancerIQ, a precision cancer prevention platform, to expand its offering to include CancerIQ’s Tyrer-Cuzick 8 risk calculator, as well as its care management and patient activation capabilities. With this partnership, Densitas will offer CancerIQ’s Tyrer-Cuzick 8 risk calculator alongside its mammography […]

Defining Excellence in Mammography Quality: Densitas and University Radiology Group Partner to Implement intelliMammo® A.I. Platform

November 22, 2023

HALIFAX, NS – November 21, 2023 – Densitas Inc, a pioneer in artificial intelligence software solutions for breast cancer screening, announces its strategic partnership with University Radiology Group (URG) through the deployment of its intelliMammo® A.I. platform. This collaboration stands as a testament to both organizations’ dedication to elevating the standards of mammography quality and patient care. URG has chosen […]

Densitas Unveils intelliMaven™ at RSNA: Your NextGen AI Solution for Mammography Quality Assurance

November 16, 2023

HALIFAX, NS, Nov. 16, 2023 /PRNewswire/ – Densitas®, a global leader in artificial intelligence solutions for breast cancer screening, announces the launch of intelliMaven™, a groundbreaking NextGen AI solution for mammography. Set to be featured at the Radiological Society of North America (RSNA) 2023 Annual Meeting, intelliMaven™ is poised to transform the way mammography quality assurance is delivered and provide a scalable and sustainable […]

Densitas and Intelerad Forge Strategic Partnership to Advance Breast Cancer Screening with Innovative A.I. Technology

October 24, 2023

Raleigh, NC and HALIFAX, NS, October 17, 2023 – Densitas®, a global leader in artificial intelligence solutions for breast cancer screening, announced a strategic partnership with Intelerad Medical Systems®, a leading provider of medical imaging software and services. This partnership strengthens clinical decision-making, increases operational efficiencies, reduces costs, and improves mammography quality and mammography facility adherence with MQSA EQUIP standards. “We are excited […]

Groundbreaking Mammo IQ Multicenter Study Unlocks Insights in Mammography Clinical Image Quality During the COVID-19 Pandemic, Made Possible by State-of-the-Art A.I.

September 28, 2023

VALENCIA, SPAIN, September 28, 2023 – Three original research presentations stemming from the Mammo IQ multi-center study spanning 7 breast screening services (BSSs) in 4 countries across North America and Europe are being showcased at the European Society for Breast Imaging (EUSOBI) Annual Congress, Valencia, Spain. The Mammo IQ study includes over 250,000 mammograms from 7 BSSs spanning the period […]

Breaking Boundaries in Breast Cancer Screening: Densitas® and ScreenPoint Medical Set to Improve Patient Outcomes

June 7, 2023

HALIFAX, NS, June 7, 2023 /CNW/ – Densitas® Inc., a global provider of A.I. solutions for digital mammography and breast screening, today announced a strategic partnership with ScreenPoint Medical, a developer of innovative breast imaging solutions. The companies will work together to increase the reach of their industry-leading AI solutions, transforming the delivery of care for both mammography providers and patients. High-quality […]

Densitas® and Blackford Expand Partnership to Offer Breast Cancer Risk and Image Quality Solutions

May 12, 2022

HALIFAX, NS, May 12, 2022 /CNW/ – Densitas® Inc., a global provider of A.I. technologies for digital mammography and breast screening announced an expansion of their partnership agreement with Blackford to integrate more of Densitas®’ solutions with the Blackford Platform. “Expanding our partnership with Blackford is a natural progression to support scaling the growth of our breast cancer risk and image quality […]

1 2 3 4 Next

Solutions

Analytics
Density
Quality
Positioning

Company

About
Contact
News
Partners
Privacy Policy

Learn More

Resources
MQSA Regulations
Blog
For Media

Request a Demo